Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03457987
Other study ID # AZ 216/17
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2018
Est. completion date January 21, 2023

Study information

Verified date June 2022
Source University of Giessen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators seek to determine whether a reduced preoperative renal functional reserve predicts postoperative acute kidney injury in patients with normal estimated glomerular filtration rates undergoing elective cardiac surgery.


Description:

Although acute kidney injury (AKI) frequently complicates cardiac surgery, methods to determine AKI risk in patients without underlying kidney disease are lacking. Renal functional reserve (RFR) can be used to measure the capacity of the kidney to increase glomerular filtration rate under conditions of physiological stress and may serve as a functional marker that assesses susceptibility to injury. The investigators seek to determine whether a reduced preoperative RFR predicts postoperative AKI in patients with normal estimated glomerular filtration rates undergoing elective cardiac surgery. All centres will measure RFR with creatinine clearance, except University Hospital Giessen where in addition iohexol plasma-clearance will be used.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date January 21, 2023
Est. primary completion date June 23, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Subjects older than 18 years 2. Subjects undergoing elective cardiac surgery (with or without cardiopulmonary bypass) 3. Subjects with an estimated GFR =60 ml/min/1.73 m2 (CKD-Epidemiology Collaboration equation) 4. Subjects who signed informed consent forms Exclusion Criteria: 1. Preexisting acute kidney injury (as determined by all available serum creatinine values from hospital and outpatient medical records within the previous 90 days) 2. Chronic kidney disease = stage III (KDIGO) 3. Subjects undergoing transcatheter aortic valve implantation (TAVI) 4. Pregnancy 5. Solitary kidney 6. Diabetes mellitus type 1 7. Recent cardiac arrest (within last 3 months) 8. Liver failure or cirrhosis 9. Total parenteral nutrition 10. Hemoglobin <11 g/dl 11. Sepsis 12. History of malabsorption, chronic inflammatory bowel disease, short bowel, or pancreatic insufficiency 13. Transplant donor or recipient 14. Active autoimmune disease with renal involvement 15. Rhabdomyolysis 16. Prostate hypertrophy with International Prostate Symptom Score =20 17. Active neoplasm 18. Decompensated heart failure / inability to pause angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers minimum 2 days before protein load 19. Known iodine allergy (exclusion criteria only for those centres who use iohexol plasma clearance for determination of GFR) 20. TSH <0.3 µU/l (exclusion criteria only for those centres who use iohexol) 21. Subjects who received intravenous radiocontrast agents within the 72 hours before the protein load 22. Subjects who received NSAIDs within 48 hours before the protein load

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Germany University Clinic Giessen and Marburg - Campus Giessen Gießen Hessen

Sponsors (7)

Lead Sponsor Collaborator
University of Giessen Azienda Ospedaliero Universitaria Maggiore della Carita, Charite University, Berlin, Germany, Guy's and St Thomas' NHS Foundation Trust, Ospedale San Bortolo di Vicenza, Robert Bosch Medical Center, Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

Germany, 

References & Publications (4)

Husain-Syed F, Ferrari F, Sharma A, Danesi TH, Bezerra P, Lopez-Giacoman S, Samoni S, de Cal M, Corradi V, Virzi GM, De Rosa S, Mucino Bermejo MJ, Estremadoyro C, Villa G, Zaragoza JJ, Caprara C, Brocca A, Birk HW, Walmrath HD, Seeger W, Nalesso F, Zanell — View Citation

Husain-Syed F, Ferrari F, Sharma A, Hinna Danesi T, Bezerra P, Lopez-Giacoman S, Samoni S, de Cal M, Corradi V, Virzi GM, De Rosa S, Mucino Bermejo MJ, Estremadoyro C, Villa G, Zaragoza JJ, Caprara C, Brocca A, Birk HW, Walmrath HD, Seeger W, Nalesso F, Z — View Citation

Ronco C, Kellum JA, Haase M. Subclinical AKI is still AKI. Crit Care. 2012 Jun 21;16(3):313. doi: 10.1186/cc11240. — View Citation

Sharma A, Zaragoza JJ, Villa G, Ribeiro LC, Lu R, Sartori M, Faggiana E, de Cal M, Virzi GM, Corradi V, Brocca A, Husain-Syed F, Brendolan A, Ronco C. Optimizing a kidney stress test to evaluate renal functional reserve. Clin Nephrol. 2016 Jul;86(7):18-26 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Whether a reduced preoperative RFR =15 ml/min/1.73 m2 increased the odds ratio for postoperative acute kidney injury in patients undergoing elective cardiac surgery. Renal functional reserve Preoperative
Secondary determine preoperative RFR accuracy based on receiver operating characteristic curve curve to predict acute kidney injury. Renal functional reserve Preoperative
Secondary To analyze an acute kidney injury risk prediction model based on clinical covariates. Renal functional reserve Preoperative
Secondary Mortality at 30 and 90 days Mortality 30 and 90 days after surgery
Secondary Length of stay in intensive care unit and hospital. Hospital stay Postoperative
Secondary Use and duration of renal replacement therapy during hospital stay. Renal replacement therapy Postoperative
Secondary Renal replacement therapy dependence at days 30 and 90. Renal replacement therapy 30 and 90 days after surgery
Secondary To evaluate renal function at three months after surgery. Estimated glomerular filtration rate 3 months after surgery
Secondary To evaluate whether preoperative RFR is correlated to renal function at three months after surgery. Renal functional reserve Preoperative
Secondary To evaluate whether chronic kidney disease is associated to preoperative RFR. Renal functional reserve Preoperative
See also
  Status Clinical Trial Phase
Recruiting NCT05538351 - A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Completed NCT03938038 - Guidance of Ultrasound in Intensive Care to Direct Euvolemia N/A
Recruiting NCT05805709 - A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial N/A
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Recruiting NCT05897840 - Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients N/A
Recruiting NCT04986137 - Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
Terminated NCT04293744 - Acute Kidney Injury After Cardiac Surgery N/A
Completed NCT04095143 - Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
Not yet recruiting NCT06026592 - Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
Not yet recruiting NCT06064305 - Transcriptional and Proteomic Analysis of Acute Kidney Injury
Terminated NCT03438877 - Intensive Versus Regular Dosage For PD In AKI. N/A
Terminated NCT03305549 - Recovery After Dialysis-Requiring Acute Kidney Injury N/A
Completed NCT05990660 - Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery N/A
Completed NCT04062994 - A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
Terminated NCT02860130 - Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT) Phase 3
Completed NCT06000098 - Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
Not yet recruiting NCT05548725 - Relation Between Acute Kidney Injury and Mineral Bone Disease
Completed NCT02665377 - Prevention of Akute Kidney Injury, Hearttransplant, ANP Phase 3
Terminated NCT03539861 - Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients N/A